Revolution Medicines Inc (RVMD) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Revolution Medicines Inc   (NASDAQ: RVMD)


Revolution Medicines Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Revolution Medicines Inc 's ROA in the second quarter of 2026?
Revolution Medicines Inc had a negative return on assets (ROA) of -63.25%, due to the net loss of $-1 billion, during the twelve months ending in the second quarter of 2026.

However, within the Healthcare sector 634 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4015, from total ROA ranking in the first quarter of 2026 at 4574.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 77.94 % -4.72 % -3.51 % 33.37 % 40.29 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -1,768 -1,372 -1,131 -961 -812
Return On Assets (TTM) -63.25 % -59.06 % -48.13 % -40.52 % -36.4 %
RVMD's Total Ranking # 4015 # 4574 # 3900 # 3882 # 3897
Total Assets (TTM) in million 4,323 2,254 2,355 2,252 2,430
Seq. Total Assets Change 91.83 % -4.28 % 4.56 % -7.31 % 2.71 %
Seq. Net Income Change - - - - -

RVMD's 5 Years Annual ROA >> Back to RVMD Management Effectiveness >> Compare RVMD ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 89
Sector # 635
Overall # 4028

Return On Assets Statistics
High Average Low
-3.38 %
-32.23 %
-63.25 %
(Mar 31 2020)   (Jun 30 2026)





Financial Statements
Revolution Medicines Inc 's Assets $ 4,323 million RVMD's Balance sheet
Revolution Medicines Inc 's Income $ -644 million Quarterly RVMD's Income Statement
RVMD's Income by Division See RVMD's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -3.51 % 23.03 % 161.93 % 11.39 % 25.52 %
Total Assets in million 2,355 2,440 1,983 757 680
Y / Y Net Income Change - - - - -
Net Income in million -1,131 -600 -436 -249 -187
Annual Return On Assets -48.05 % -24.59 % -22 % -32.84 % -27.52 %

RVMD's 5 Years Annual ROA >> Back to RVMD Management Effectiveness >> Compare RVMD ROA to its Competitors



More Return On Assets Ratios
RVMD's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
RVMD's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for RVMD's Competitors
Subscribers only: Roa for Revolution Medicines Inc 's Suppliers
Subscribers only: Return On Assets for RVMD's Customers

You may also want to know
RVMD's Roi RVMD's Inventory Turnover Ratio RVMD's Growth Rates RVMD's Dividend Comparisons
RVMD's Profitability Ratios RVMD's Asset Turnover Ratio RVMD's Dividend Growth
RVMD's Roe RVMD's Valuation Ratios RVMD's Financial Strength Ratios RVMD's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-10T17:22:01+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.